Jim Simons Immucell Corp Transaction History

Renaissance Technologies LLC

$56.7 Billion
Q2 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Immucell Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 125,589 shares of ICCC stock, worth $448,352. This represents 0.0% of its overall portfolio holdings.

Number of Shares

125,589

Previous 124,889 0.56%

Holding current value

$448,352

Previous $662,000 8.01%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$4.18 - $5.48 $2,926 - $3,836	700 Added 0.56%	125,589 $609,000
Q1 2024 May 13, 2024	SELL	$4.73 - $5.47 $6,149 - $7,111	-1,300 Reduced 1.03%	124,889 $662,000
Q4 2023 Feb 13, 2024	BUY	$4.45 - $5.47 $21,400 - $26,305	4,809 Added 3.96%	126,189 $642,000
Q3 2023 Nov 14, 2023	SELL	$4.53 - $5.61 $4,570 - $5,660	-1,009 Reduced 0.82%	121,380 $648,000
Q2 2023 Aug 11, 2023	SELL	$4.64 - $5.98 $2,032 - $2,619	-438 Reduced 0.36%	122,389 $612,000
Q1 2023 May 12, 2023	SELL	$4.85 - $7.84 $12,910 - $20,870	-2,662 Reduced 2.12%	122,827 $633,000
Q4 2022 Feb 13, 2023	SELL	$6.09 - $8.25 $73,670 - $99,800	-12,097 Reduced 8.79%	125,489 $765,000
Q3 2022 Nov 14, 2022	SELL	$7.04 - $9.1 $114,055 - $147,429	-16,201 Reduced 10.53%	137,586 $1.03 Million
Q2 2022 Aug 12, 2022	SELL	$7.7 - $10.71 $6,098 - $8,482	-792 Reduced 0.51%	153,787 $1.34 Million
Q1 2022 May 13, 2022	SELL	$8.0 - $10.06 $104,296 - $131,152	-13,037 Reduced 7.78%	154,579 $1.49 Million
Q4 2021 Feb 11, 2022	SELL	$8.0 - $9.74 $69,648 - $84,796	-8,706 Reduced 4.94%	167,616 $1.34 Million
Q3 2021 Nov 12, 2021	SELL	$8.54 - $10.24 $15,662 - $18,780	-1,834 Reduced 1.03%	176,322 $1.65 Million
Q2 2021 Aug 13, 2021	SELL	$8.5 - $10.95 $80,087 - $103,170	-9,422 Reduced 5.02%	178,156 $1.69 Million
Q1 2021 May 13, 2021	BUY	$5.98 - $11.88 $116,161 - $230,769	19,425 Added 11.55%	187,578 $1.81 Million
Q4 2020 Feb 10, 2021	BUY	$5.21 - $6.42 $62,681 - $77,239	12,031 Added 7.71%	168,153 $1 Million
Q3 2020 Nov 13, 2020	BUY	$4.98 - $6.35 $91,881 - $117,157	18,450 Added 13.4%	156,122 $848,000
Q2 2020 Aug 13, 2020	BUY	$3.95 - $4.9 $78,210 - $97,020	19,800 Added 16.8%	137,672 $651,000
Q1 2020 May 14, 2020	BUY	$3.79 - $5.92 $29,433 - $45,974	7,766 Added 7.05%	117,872 $447,000
Q4 2019 Feb 13, 2020	BUY	$4.81 - $5.57 $67,340 - $77,980	14,000 Added 14.57%	110,106 $567,000
Q3 2019 Nov 13, 2019	BUY	$5.15 - $6.55 $21,115 - $26,855	4,100 Added 4.46%	96,106 $535,000
Q2 2019 Aug 12, 2019	BUY	$5.89 - $6.86 $4,123 - $4,802	700 Added 0.77%	92,006 $598,000
Q1 2019 May 14, 2019	SELL	$5.91 - $8.09 $2,955 - $4,045	-500 Reduced 0.54%	91,306 $580,000
Q4 2018 Feb 13, 2019	BUY	$6.4 - $9.03 $587,558 - $829,008	91,806 New	91,806 $647,000

Others Institutions Holding ICCC

# of Institutions

Shares Held

1.13M

Call Options Held

Put Options Held

View Full List

About IMMUCELL CORP

Ticker ICCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,746,860
Market Cap $27.7M
Description
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...

More about ICCC

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account